UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Opdivo’s indication expanded to esophageal squamous cell carcinoma
by Kim Yun-mi
2020-04-16 10:48
Despite Covid-19, voters show highest turnout since 2000
by Shim Hyun-tai
2020-04-15 19:18
‘New algorithm can read age, gender via retinal image’
by Shim Hyun-tai
2020-04-14 17:49
Pasteur, Daewoong to co-develop COVID-19 drug from parasiticide
by Shim Hyun-tai
2020-04-14 17:49
‘Stealth transmission could still fuel COVID-19 spread’
by Song Soo-youn
2020-04-14 17:31
라인
What are the odds for successful Invossa trials in US?
by Jeong Sae-im
2020-04-14 15:01
New virus cases stay below 30
by Shim Hyun-tai
2020-04-14 14:09
AI model developed to predict survival in prostate cancer patients
by Kim Yoon-mi
2020-04-14 11:33
Bio-health industry's exports benefit from COVID-19
by Shim Hyun-tai
2020-04-13 18:16
Celltrion gets antibody candidates neutralizing new coronavirus
by Shim Hyun-tai
2020-04-13 18:16
라인
‘Robotic surgery better than laparoscope operation in gastric cancer’
by Kim Yoon-mi
2020-04-13 16:03
Korea’s radiation dose management system sells briskly in Europe
by Shim Hyun-tai
2020-04-13 15:44
COVID-19 vaccine trial likely to start in April
by Song Soo-youn
2020-04-13 15:44
New virus cases remain below 30 for 5th day
by Shim Hyun-tai
2020-04-13 12:30
FDA OKs resumption of phase-3 Invossa trial in US
by Jeong Sae-im
2020-04-13 11:58
라인
Myongji Hospital leads Korea’s fight against COVID-19
by Kim Yoon-mi
2020-04-13 10:31
COVID-19 cure rate tops 70% amid slowing new cases
by Shim Hyun-tai
2020-04-12 18:05
New virus cases fall below 30 for 1st time in 50 days
by Shim Hyun-tai
2020-04-10 18:12
Korean researchers unveil genome map of COVID-19 for 1st time
by Shim Hyun-tai
2020-04-10 18:08
Samsung signs contract with Vir to make COVID-19 treatment
by Shim Hyun-tai
2020-04-10 18:07
-
이전
41
42
43
44
45
46
47
48
49
50
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top